1Dermietzel R, Spray DC. Gap junctions in the brain: where, what type, how many and why? [ J ]. Trends Neurosci, 1993, 16 ( 1 ) : 186 -192
2Ben N, Giepmans G. Gap junctions and connexin-interacting proteins[J]. Cardiovascular Research, 2004,62 (2) : 233 - 245
3Martin PE,Blundell G, Ahmad S, et al. Multiple pathways in the trafficking and assembly of connexin 26,32 and 43 into gap junction intercellular communication channels[J].Cell Sci,2001,114(2) :3845 -3855
4Koval M. Pathways and control of connexin oligomerization [ J ].Trends Cell Biol,2006,18(2) :261 - 272
5Wilson MR, Close TW, Trosko JE. Cell population dynamics(apoptosis, mitosis, and cell cell communication) during disruption of homeostasis[J]. Cell Res,2000,25(4) :257 - 268
6Nodin C, Nilsson M, Blomstrand F. Gap junction blockage limits intercellular spreading of astrocytic apoptosis induced by metabolic depression[J]. Neurochem,2005,94(4):1111-1123
7Kalvelyte A, Imbrasaite A, Bukauskiene A, et al. Connexins and apoptotic transformation[J]. Biochem,2003,66(4):1661-1672
8Cusato K, Ripps H, Zakevicius J, et al. Gap junctions remain open during cytoehrome c-induced cell death: relationship of conductance to' bystander' cell killing [ J ]. Cell Death Differ, 2006,17 (2):167 -172
9Perez Velazquez JL, Kokarovtseva L, Sarbaziha R, et al. Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-indueed oxidative stress and hippocampal damage[J]. Neurosci,2006,23(1) :1 - 10
2Zundoff G, Kahlert S, Reiser G. Gap-junction blocker carbenoxolone differentially enhances NMDA induced cell death in hippoal neurons and astrocytes in co-culture [J]. J Neuro Chem, 2007, 102 (2) : 508-521.
3Koulakoff A, Ezan P, Giaume C. Neurons control the expression of connexin30 and connexin43 in mouse cortial astrocytes [ J ]. Glia, 2008, 56 (9): 1299-1311.
4McCarthy K D, De Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue [ J ]. J Cell Biol, 1980, 85 (3) : 890-902.
5Di Monte D A, Lavasani M, Manning-Bog A B. Environmental factors in Parkinson's disease [ J ]. Neurotoxicology, 2002, 23 ( 4-5 ) : 487 -502.
6Herishanu Y O, Medvedovski M, Goldsmith J R, et al. A case-control study of Parkinson's disease in urban population of southem israel [J]. Can J Neurol Sci, 2001, 28 (2) : 144-147.
7Toshiki H, Naoto K, Yuko K, et al. Neuroprotective effect of arundic acid, an astrocyte-modulating agent in mouse brain against MPTP neurotoxicity [J]. Neuropharmacology, 2006, 50 (3): 329-344.
